![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Suzhou No.5 Pharmaceutical Factory Co., Ltd. Suzhou Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Nifuroxazide, supported by a 'Withdrawn by EDQM Failure to CEP procedure' Certificate of Suitability (CEP) with the number R0-CEP 2006-074 - Rev 00
This Chemical Type CEP, issued on May 06, 2010, remains in force until March 20, 2014, ensuring its reliability within the pharmaceutical industry.
Substance Number 1999 associated with this CEP further emphasizes